Skip to content

Efficiency Study of Traditional Chinese Medicine (TCM) Versus Western Medicine (WM) on Ischemic Stroke

Program of TCM on Early Rehabilitation and Secondary Prevention of Ischemic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00843765
Enrollment
1151
Registered
2009-02-13
Start date
2007-12-31
Completion date
2010-11-30
Last updated
2012-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Traditional Chinese Medicine, Rehabilitation

Brief summary

Complex project of Traditional Chinese Medicine (TCM) with Western Medicine (WM) project under stroke unit mode contrast,assuming that the efficiency of TCM on early rehabilitation and secondary prevention of ischemic stroke is same or better than that of WM.

Detailed description

As a multi-site randomized controlled clinical trial,through a central system,patients were randomly assigned to the intervention group or the control group.In the intervention group, patients were treated with the traditional Chinese medicine comprehensive rehabilitation program, which includes traditional Chinese medicine syndrome differentiation herbs, Chinese medicine injection, wash foam Chinese medicine, acupuncture,massage, and Chinese medicine health education. In the control group, patients were treated with Western-based treatment plus modern rehabilitation techniques.All patients were treated for 2 weeks. At the first day after the treatment and the 14 days after treatment, each patient was evaluated for the following three clinical indications: (1)evaluation of neurological deficits by U.S. National Institutes of Health Stroke Scale (NIHSS);(2) evaluation of motor function by the short form Fugl-Meyer motor function scoring system (FMI); and (3) assessment of limb spasticity by the modified Ashworth spasticity rating scale.

Interventions

OTHERacupuncture, massage and basic TCM treatment

1. During hospitalization:Patients accept TCM rehabilitation and basic treatment including WM basic treatment and Chinese medicine injection,decoction,herb soak treatment and health education. 2. After discharge from hospital: In the TCM group,add prescriptions according to two conditions:a. patients using A injection (one Chinese herb injection admitted by SFDA) will take A' capsule (one Chinese herb capsule admitted by SFDA) for 6 months;b.patients using B injection (ditto) will take B' capsule (ditto) for 6 months.Both of them will accept TCM health education.In the WM group, patients are suggested with targeted rehabilitation programs according to different causes.

OTHERrehabilitation and WM basic treatment

there two steps: 1. during hospitalization: patients accept modern rehabilitation and basic treatment of life supporting and medicine using and health education 2. After discharge: make rehabilitation plans for patients including management of anticoagulant drugs, blood pressure, blood lipid and blood glucose, health education, and some suggestions for resisting alcohol ,smoking and reasonable diet

Sponsors

Dongzhimen Hospital, Beijing
CollaboratorOTHER
Beijing Tiantan Hospital
CollaboratorOTHER
China Academy of Chinese Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* According with the stroke diagnosis of Traditional Chinese Medicine * According to atherosclerotic thrombotic cerebral infarction from Western diagnosis such as medical history and CT / MRI examinations * It has attacked in 7 days * The assessment of scale of NIHSS:4-24 points * Age: ≥ 35 years and ≤ 75 years * Patients or their legal guardians sign informed consent form

Exclusion criteria

* The patients with ICH or cerebral hemorrhage or TIA * It has attacked beyond 7 days * Patients with stroke history and the mRS ≥ 2 points before this attack * Mixed type of stroke (infarction after bleeding or bleeding after infarction) * Patients with cerebral infarction by cardiogenic embolism, blood hypercoagulable state and tunica intima exfoliating * Patients with serious heart disease;failure of heart or liver or kidney; cancer;digestive tract bleeding * Women of pregnancy or breast-feeding * Patients who are taking part in other clinical trials that will influence the results of this study

Design outcomes

Primary

MeasureTime frame
NIHSS Stroke Scale, relapse rate360 days

Secondary

MeasureTime frame
adverse event360 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026